Falcon Genomics Wins $270K NIH Grant to Develop Breast Cancer Biochip

Pittsburgh-based Falcon Genomics has to date marketed its Cancer Biochip System for research purposes. The firm hopes to use the new funds to move the platform into the clinical arena.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.